← All trials
NCT05385861
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2022
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2024
- First posted
- May 23, 2022
- Last posted
- May 23, 2022
- Enrollment
- 52
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of TaiwanLead sponsor
- Chang Gung UniversityCollaborator
- Kaohsiung Medical UniversityCollaborator
- National Cheng Kung UniversityCollaborator
- Taipei Veteran General hospitalCollaborator
- Taiwan Cooperative Oncology GroupStudy director
- China Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.